» Articles » PMID: 24349779

Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs

Overview
Specialty Public Health
Date 2013 Dec 19
PMID 24349779
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background. The use of prostate-specific antigen test has markedly increased in Danish general practice in the last decade. Despite the national guidelines advice against PSA screening, opportunistic screening is supposed to be the primary reason for this increased number of PSA tests performed. Aims. Based on the increase in the amount of PSA conducted, we aimed to analyse how GPs in Denmark use the PSA test. Methods. A self-administrated questionnaire concerning symptomatic and asymptomatic patient cases was developed based on the national and international guidelines and the extensive literature review, and an in-depth interview conducted with a GP was performed. Results. None of the GPs would do a PSA measurement for an asymptomatic 76-year-old man. For asymptomatic 55- and 42-year-old men, respectively, 21.9% and 18.6% of GPs would measure PSA. Patient request and concern could be potential reasons for measuring PSA for asymptomatic patients. Almost all GPs stated that a PSA measurement is indicated for symptomatic 49- and 78-year-old men, respectively, 98.9% and 93.8%. Conclusion. Opportunistic PC screening is being performed in general practice to a high degree. Hence, current guidelines are not followed, and intense focus should be on more effective implementation strategies in order to avoid overuse of PSA.

Citing Articles

Atrial Fibrillation and Risk of Cancer: A Danish Population-Based Cohort Study.

Vinter N, Christesen A, Fenger-Gron M, Tjonneland A, Frost L J Am Heart Assoc. 2018; 7(17):e009543.

PMID: 30371150 PMC: 6201425. DOI: 10.1161/JAHA.118.009543.


Drivers and strategies for avoiding overuse. A cross-sectional study to explore the experience of Spanish primary care providers handling uncertainty and patients' requests.

Mira J, Carrillo I, Silvestre C, Perez-Perez P, Nebot C, Olivera G BMJ Open. 2018; 8(6):e021339.

PMID: 29909371 PMC: 6009548. DOI: 10.1136/bmjopen-2017-021339.


Impact of CAre-related Regret Upon Sleep (ICARUS) cohort study: protocol of a 3-year multicentre, international, prospective cohort study of novice healthcare professionals.

Cheval B, Cullati S, Pihl-Thingvad J, Mongin D, von Arx M, Chopard P BMJ Open. 2018; 8(3):e022172.

PMID: 29588326 PMC: 5875595. DOI: 10.1136/bmjopen-2018-022172.


Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data.

Merriel S, May M, Martin R BMJ Open. 2018; 8(1):e019409.

PMID: 29391368 PMC: 5829815. DOI: 10.1136/bmjopen-2017-019409.


Men's perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia.

Kirkman M, Young K, Evans S, Millar J, Fisher J, Mazza D BMC Cancer. 2017; 17(1):704.

PMID: 29078768 PMC: 5659031. DOI: 10.1186/s12885-017-3699-1.


References
1.
Sorum P, Mullet E, Shim J, Bonnin-Scaon S, Chasseigne G, Cogneau J . Avoidance of anticipated regret: the ordering of prostate-specific antigen tests. Med Decis Making. 2004; 24(2):149-59. DOI: 10.1177/0272989X04263163. View

2.
Sorum P, Shim J, Chasseigne G, Bonnin-Scaon S, Cogneau J, Mullet E . Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients?. Med Decis Making. 2003; 23(4):301-13. DOI: 10.1177/0272989X03256010. View

3.
Jonler M, Eddy B, Poulsen J . Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark. Scand J Urol Nephrol. 2005; 39(3):214-8. DOI: 10.1080/00365590510031084. View

4.
Schroder F, Hugosson J, Roobol M, Tammela T, Ciatto S, Nelen V . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320-8. DOI: 10.1056/NEJMoa0810084. View

5.
McNaughton-Collins M, Fowler Jr F, Caubet J, Bates D, Lee J, Hauser A . Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med. 2004; 117(10):719-25. DOI: 10.1016/j.amjmed.2004.06.036. View